[-] Show simple item record

dc.contributor.authorEvensen, Ann E.eng
dc.contributor.authorElliott, Margueriteeng
dc.contributor.authorHooper-Lane, Christophereng
dc.date.issued2010-12eng
dc.description.abstractPatients who have coronary heart disease (CHD) or are at high risk for CHD should aim for a low-density lipoprotein (LDL) target of <100 mg/dL. An LDL target of <70 mg/dL is an option for very-high-risk patients (strength of recommendation [SOR]: C, expert opinion). The evidence also indicates that high-risk patients benefit from a statin—preferably in high doses—regardless of their baseline LDL or degree of LDL reduction with treatment (SOR: A, a large randomized controlled trial [RCT] and meta-analyses).eng
dc.identifier.citationJournal of Family Practice, 59(12) 2010: 706-708.eng
dc.identifier.urihttp://hdl.handle.net/10355/9436eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2010 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesClinical inquiries ; volume 59, no. 12, 2010eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectcholesterol managementeng
dc.subjectrisk factorseng
dc.subject.lcshLow density lipoproteinseng
dc.subject.lcshCoronary heart diseaseeng
dc.subject.lcshStatins (Cardiovascular agents)eng
dc.titleWhich patients benefit from lowering LDL to <100 mg/dL?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record